On February 19, Annika F. Barber started counting.
Barber, an assistant professor of molecular biology and biochemistry at Rutgers University at New Brunswick, had been gearing up for a meeting in which she and other experts would review grant applications to the National Institutes of Health. These convenings of study sections, as they’re known, are the first step in deciding who gets NIH funding. But they’ve slowed to a standstill since the Trump administration’s announcement in late January of a freeze on trillions in federal funding. To read the full story.